BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31572793)

  • 1. Test-Retest Performance of a 1-Hour Multiparametric MR Image Acquisition Pipeline With Orthotopic Triple-Negative Breast Cancer Patient-Derived Tumor Xenografts.
    Ge X; Quirk JD; Engelbach JA; Bretthorst GL; Li S; Shoghi KI; Garbow JR; Ackerman JJH
    Tomography; 2019 Sep; 5(3):320-331. PubMed ID: 31572793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DCE- and DW-MRI as early imaging biomarkers of treatment response in a preclinical model of triple negative breast cancer.
    Barnes SL; Sorace AG; Whisenant JG; McIntyre JO; Kang H; Yankeelov TE
    NMR Biomed; 2017 Nov; 30(11):. PubMed ID: 28915312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Effects of Anti-PD-1 Therapy on Triple-Negative Breast Cancer in Mice by Diffusion Kurtosis Imaging and Dynamic Contrast-Enhanced Imaging.
    Tang WJ; Yao W; Jin Z; Kong QC; Hu WK; Liang YS; Chen LX; Chen SY; Zhang QQ; Wei XH; Xu XD; Guo Y; Jiang XQ
    J Magn Reson Imaging; 2022 Dec; 56(6):1912-1923. PubMed ID: 35499275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial Intelligence-Based Classification of Breast Lesions Imaged With a Multiparametric Breast MRI Protocol With Ultrafast DCE-MRI, T2, and DWI.
    Dalmiş MU; Gubern-Mérida A; Vreemann S; Bult P; Karssemeijer N; Mann R; Teuwen J
    Invest Radiol; 2019 Jun; 54(6):325-332. PubMed ID: 30652985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric MRI Features of Breast Cancer Molecular Subtypes.
    Szep M; Pintican R; Boca B; Perja A; Duma M; Feier D; Fetica B; Eniu D; Dudea SM; Chiorean A
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
    Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
    Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple-negative breast cancer on contrast-enhanced MRI and synthetic MRI: A comparison with non-triple-negative breast carcinoma.
    Matsuda M; Tsuda T; Ebihara R; Toshimori W; Okada K; Takeda S; Okumura A; Shiraishi Y; Suekuni H; Kamei Y; Kurata M; Kitazawa R; Mochizuki T; Kido T
    Eur J Radiol; 2021 Sep; 142():109838. PubMed ID: 34217136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multiparametric approach to predict triple-negative breast cancer including parameters derived from ultrafast dynamic contrast-enhanced MRI.
    Ohashi A; Kataoka M; Iima M; Honda M; Ota R; Urushibata Y; Dominik Nickel M; Toi M; Zackrisson S; Nakamoto Y
    Eur Radiol; 2023 Nov; 33(11):8132-8141. PubMed ID: 37286791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.
    Kim JJ; Kim JY; Suh HB; Hwangbo L; Lee NK; Kim S; Lee JW; Choo KS; Nam KJ; Kang T; Park H
    Eur Radiol; 2022 Feb; 32(2):822-833. PubMed ID: 34345946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC).
    Abdelhafez AH; Musall BC; Adrada BE; Hess K; Son JB; Hwang KP; Candelaria RP; Santiago L; Whitman GJ; Le-Petross HT; Moseley TW; Arribas E; Lane DL; Scoggins ME; Leung JWT; Mahmoud HS; White JB; Ravenberg EE; Litton JK; Valero V; Wei P; Thompson AM; Moulder SL; Pagel MD; Ma J; Yang WT; Rauch GM
    Breast Cancer Res Treat; 2021 Jan; 185(1):1-12. PubMed ID: 32920733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Axillary Lymph Node Metastasis in Early-stage Triple-Negative Breast Cancer Using Multiparametric and Radiomic Features of Breast MRI.
    Song SE; Woo OH; Cho Y; Cho KR; Park KH; Kim JW
    Acad Radiol; 2023 Sep; 30 Suppl 2():S25-S37. PubMed ID: 37331865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
    Li X; Abramson RG; Arlinghaus LR; Kang H; Chakravarthy AB; Abramson VG; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Grau AM; Sanders M; Yankeelov TE
    Invest Radiol; 2015 Apr; 50(4):195-204. PubMed ID: 25360603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
    Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
    Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric MR Imaging with High-Resolution Dynamic Contrast-enhanced and Diffusion-weighted Imaging at 7 T Improves the Assessment of Breast Tumors: A Feasibility Study.
    Pinker K; Baltzer P; Bogner W; Leithner D; Trattnig S; Zaric O; Dubsky P; Bago-Horvath Z; Rudas M; Gruber S; Weber M; Helbich TH
    Radiology; 2015 Aug; 276(2):360-70. PubMed ID: 25751227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved discrimination of molecular subtypes in invasive breast cancer: Comparison of multiple quantitative parameters from breast MRI.
    Du S; Gao S; Zhang L; Yang X; Qi X; Li S
    Magn Reson Imaging; 2021 Apr; 77():148-158. PubMed ID: 33309922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of tumor characteristics derived from DCE-MRI and DW-MRI with histology in murine models of breast cancer.
    Barnes SL; Sorace AG; Loveless ME; Whisenant JG; Yankeelov TE
    NMR Biomed; 2015 Oct; 28(10):1345-56. PubMed ID: 26332194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined diagnosis of multiparametric MRI-based deep learning models facilitates differentiating triple-negative breast cancer from fibroadenoma magnetic resonance BI-RADS 4 lesions.
    Yin HL; Jiang Y; Xu Z; Jia HH; Lin GW
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2575-2584. PubMed ID: 35771263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical PERCIST and 25% of SUV
    Savaikar MA; Whitehead T; Roy S; Strong L; Fettig N; Prmeau T; Luo J; Li S; Wahl RL; Shoghi KI
    J Nucl Med; 2020 Jun; 61(6):842-849. PubMed ID: 31757841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study.
    Luo J; Hippe DS; Rahbar H; Parsian S; Rendi MH; Partridge SC
    Breast Cancer Res; 2019 Sep; 21(1):102. PubMed ID: 31484577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.